Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-01-07 @ 12:57 AM
Study NCT ID:
NCT03280667
Status:
UNKNOWN
Last Update Posted:
2023-03-29
First Post:
2017-09-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma
Sponsor:
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ANZUP1601
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None